Experience with netarsudil 0.02% and latanoprostene bunod 0.024% as adjunctive therapy for glaucoma.
Mehta AA, Kanu LN, Sood-Mendiratta S, Quinones R, Hawkins A, Lehrer RA, Malhotra K, Papas R, Hillman D, Wilensky JT, Aref AA, Vajaranant TS, Edward DP.
Mehta AA, et al. Among authors: vajaranant ts.
Eur J Ophthalmol. 2022 Jan;32(1):322-326. doi: 10.1177/1120672121998913. Epub 2021 Mar 2.
Eur J Ophthalmol. 2022.
PMID: 33653172